Title |
Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer
|
---|---|
Published in |
PLOS ONE, March 2012
|
DOI | 10.1371/journal.pone.0033976 |
Pubmed ID | |
Authors |
Robin M. Hallett, Maria K. Kondratyev, Andrew O. Giacomelli, Allison M. L. Nixon, Adele Girgis-Gabardo, Dora Ilieva, John A. Hassell |
Abstract |
Recent evidence suggests that human breast cancer is sustained by a minor subpopulation of breast tumor-initiating cells (BTIC), which confer resistance to anticancer therapies and consequently must be eradicated to achieve durable breast cancer cure. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Portugal | 2 | 2% |
United States | 2 | 2% |
Germany | 1 | <1% |
Netherlands | 1 | <1% |
Brazil | 1 | <1% |
Korea, Republic of | 1 | <1% |
United Kingdom | 1 | <1% |
Poland | 1 | <1% |
Unknown | 108 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 37 | 31% |
Researcher | 26 | 22% |
Student > Master | 10 | 8% |
Student > Bachelor | 9 | 8% |
Student > Postgraduate | 7 | 6% |
Other | 17 | 14% |
Unknown | 12 | 10% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 43 | 36% |
Medicine and Dentistry | 27 | 23% |
Biochemistry, Genetics and Molecular Biology | 24 | 20% |
Chemistry | 6 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Other | 3 | 3% |
Unknown | 12 | 10% |